A. Hernández

First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study.

E. Miranda, P. D. Prado, M. C. Dols, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

916MO Safety and efficacy of MEDI0457 plus durvalumab in patients (pts) with human papillomavirus-associated recurrent/metastatic head and neck squamous cell carcinoma (HPV+ R/M HNSCC)

T. Seiwert, J. Boyer, A. Algazi, 2020 .

1073TiP A phase I, first-in-human, multicenter, open-label, dose-escalation study of IPH5201 as monotherapy or in combination with durvalumab ± oleclumab in advanced solid tumours

A. Italiano, J. Bendell, B. Carneiro, 2020 .

19O Preliminary safety, antitumor activity and pharmacodynamics results of HIT-IT MEDI1191 (mRNA IL-12) in patients with advanced solid tumours and superficial lesions

T. Marron, B. Carneiro, J. Eyles, 2021 .